Top compounds associated with response to CRK


Feature Type Standardized
Nominal ANOVA
mRNA IOX2 GDSC1000 pan-cancer AAC 0.13 0.001
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.002
mRNA Docetaxel GDSC1000 pan-cancer AAC 0.12 0.002
mRNA Talazoparib GDSC1000 pan-cancer AAC 0.13 0.002
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.002
mRNA thapsigargin gCSI pan-cancer AAC 0.22 0.002
mRNA AG-014699 GDSC1000 pan-cancer AAC 0.12 0.002
mRNA Rapamycin gCSI pan-cancer AAC 0.2 0.003
mRNA BMS-509744 GDSC1000 pan-cancer AAC 0.2 0.003
mRNA Gemcitabine gCSI pan-cancer AAC 0.2 0.003
Download CSV